Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Inventory: 2021-2023

Historic Inventory for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $22.7 million.

  • ADC Therapeutics' Inventory rose 44.35% to $22.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $22.7 million, marking a year-over-year increase of 44.35%. This contributed to the annual value of $12.1 million for FY2022, which is 8.55% up from last year.
  • Per ADC Therapeutics' latest filing, its Inventory stood at $22.7 million for Q3 2023, which was up 16.99% from $19.4 million recorded in Q2 2023.
  • ADC Therapeutics' Inventory's 5-year high stood at $22.7 million during Q3 2023, with a 5-year trough of $7,718 in Q2 2021.
  • Its 3-year average for Inventory is $11.4 million, with a median of $13.4 million in 2022.
  • Data for ADC Therapeutics' Inventory shows a peak YoY surged of 196,515.88% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows ADC Therapeutics' Inventory stood at $11.1 million in 2021, then increased by 8.55% to $12.1 million in 2022, then skyrocketed by 44.35% to $22.7 million in 2023.
  • Its last three reported values are $22.7 million in Q3 2023, $19.4 million for Q2 2023, and $18.2 million during Q1 2023.